We are live on ! Find out more
GPCM

Granite Point Capital Management Portfolio holdings

AUM $4.9M
1-Year Est. Return 38.41%
This Fund
S&P 500
This Quarter Est. Return
+2.1%
1 Year Est. Return
+38.41%
3 Year Est. Return
+124.67%
5 Year Est. Return
+295.96%
10 Year Est. Return
–
AUM
$125M
AUM Growth
-$131M
Cap. Flow
-$755K
Cap. Flow %
-0.6%
Top 10 Hldgs %
39.36%
Holding
112
New
21
Increased
21
Reduced
8
Closed
32

Top Buys

Rank Stock Value
1
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$4.61M
2
AXGN icon
Axogen
AXGN
+$2.46M
3
ACRS icon
Aclaris Therapeutics
ACRS
+$2.42M
4
BAC icon
Bank of America
BAC
+$2.41M
5
HDSN
Hudson Technologies
HDSN
+$1.84M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$4.91M
2
SRPT icon
Sarepta Therapeutics
SRPT
+$4.02M
3
HIMX
Himax Technologies
HIMX
+$3.25M
4
CY
Cypress Semiconductor
CY
+$2.13M
5
MEET
The Meet Group, Inc. Common Stock
MEET
+$1.81M

Sector Composition

Rank Sector Weight
1 Healthcare 34.83%
2 Technology 14.08%
3 Consumer Discretionary 12.52%
4 Miscellaneous 10.65%
5 Communication Services 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OLED icon
76
Universal Display
OLED
$3.58B
$225K 0.18%
+4,000
New +$220K
CYOU
77
CALL
DELISTED
Changyou.com Limited American Depositary Share
CYOU
$212K 0.17%
10,000
– –
CAPR icon
78
Capricor Therapeutics
CAPR
$498M
$180K 0.14%
6,750
– –
GLUU
79
DELISTED
Glu Mobile Inc.
GLUU
$136K 0.11%
70,000
– –
CCIH
80
DELISTED
Chinacache International Holdings Ltd
CCIH
$31K 0.02%
+12,100
New +$39.1K
AAPL icon
81
Apple
AAPL
$4.84T
– –
-173,600
Closed -$4.91M
AMD icon
82
Advanced Micro Devices
AMD
$823B
– –
-500,000
Closed -$544K
AZN icon
83
AstraZeneca
AZN
$251B
– –
-22,500
Closed -$1.48M
EEM icon
84
PUT
iShares MSCI Emerging Markets ETF
EEM
$30.6B
– –
-160,000
Closed -$5.99M
FXI icon
85
PUT
iShares China Large-Cap ETF
FXI
$4.1B
– –
-50,000
Closed -$1.9M
GLD icon
86
CALL
SPDR Gold Trust
GLD
$145B
– –
-80,000
Closed -$10.1M
HIMX
87
Himax Technologies
HIMX
$2.31B
– –
-430,550
Closed -$3.25M
IWM icon
88
PUT
iShares Russell 2000 ETF
IWM
$76.9B
– –
-615,000
Closed -$76.4M
LSCC icon
89
Lattice Semiconductor
LSCC
$15.1B
– –
-20,000
Closed -$130K
NOAH
90
Noah Holdings
NOAH
$559M
– –
-16,000
Closed -$418K
SHYF
91
DELISTED
The Shyft Group
SHYF
– –
-60,000
Closed -$575K
SPY icon
92
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$799B
– –
-50,000
Closed -$10.8M
SPY icon
93
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$799B
– –
-10,000
Closed -$2.16M
TCOM icon
94
CALL
Trip.com Group
TCOM
$24.7B
– –
-10,000
Closed -$466K
TCOM icon
95
Trip.com Group
TCOM
$24.7B
– –
-8,000
Closed -$373K
TXMD icon
96
TherapeuticsMD
TXMD
$25M
– –
-3,509
Closed -$1.2M
JOYY
97
JOYY Inc
JOYY
$3.78B
– –
-25,000
Closed -$1.33M
ITCI
98
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-32,500
Closed -$495K
ISEE
99
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-10,000
Closed -$461K
XLRN
100
DELISTED
Acceleron Pharma
XLRN
– –
-13,441
Closed -$486K
1 2 3
4
5

Similar funds

MAM
Moelis Asset Management New York $5.32M AUM
CCM
Compton Capital Management Providence, Rhode Island $4.32M AUM 27.38% 1-Year Est. Return
BGCI
Bertram Growth Capital III Foster City, California $6.05M AUM 39.41% 1-Year Est. Return
CAM
Chatham Asset Management Chatham, New Jersey $376K AUM
EAM
Emso Asset Management London, United Kingdom $255K AUM 6.95% 1-Year Est. Return
SM
SG3 Management Dorado, Puerto Rico $6.45K AUM 61.81% 1-Year Est. Return
TPL
Tao Pro LLC San Francisco, California $13.8M AUM 74.14% 1-Year Est. Return
RC
Resonate Capital San Francisco, California $15.4M AUM 24.26% 1-Year Est. Return

Granite Point Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, Granite Point Capital Management held 112 positions worth $125M, down 51% from $256M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Granite Point Capital Management's Q4 2016 filing shows 21 new, 21 increased, 8 reduced and 32 closed positions. Its largest new stake was Alnylam Pharmaceuticals: 110,000 shares worth $4.12M. The largest sale was Apple, an estimated $4.91M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Granite Point Capital Management's largest Q4 2016 buy was Alnylam Pharmaceuticals: 110,000 shares worth $4.12M.
  • Granite Point Capital Management added most to Axogen in Q4 2016, an estimated $2.46M increase.
  • Granite Point Capital Management's biggest Q4 2016 reduction was Sarepta Therapeutics, cutting an estimated $4.02M.
  • Granite Point Capital Management fully exited Apple in Q4 2016, selling an estimated $4.91M.
  • Granite Point Capital Management's ten largest holdings make up 39% of its $125M portfolio in Q4 2016.
  • Granite Point Capital Management opened 21 new positions and closed 32 in Q4 2016.
  • Granite Point Capital Management's portfolio value fell 51% quarter-over-quarter to $125M.

Based on Granite Point Capital Management's 13F filing for Q4 2016, filed 7 Feb 2017.